nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—EGF—telencephalic ventricle—meningioma	0.0496	0.312	CbGeAlD
Sucralfate—FGA—brainstem—meningioma	0.0184	0.116	CbGeAlD
Sucralfate—EGF—brainstem—meningioma	0.0134	0.0845	CbGeAlD
Sucralfate—PGA5—brain—meningioma	0.0126	0.0796	CbGeAlD
Sucralfate—FGA—cerebellum—meningioma	0.00905	0.057	CbGeAlD
Sucralfate—EGF—spinal cord—meningioma	0.00834	0.0525	CbGeAlD
Sucralfate—FGF2—medulla oblongata—meningioma	0.00825	0.052	CbGeAlD
Sucralfate—FGF2—spinal cord—meningioma	0.00736	0.0463	CbGeAlD
Sucralfate—FGA—brain—meningioma	0.00735	0.0463	CbGeAlD
Sucralfate—EGF—cerebellum—meningioma	0.00661	0.0416	CbGeAlD
Sucralfate—FGF2—cerebellum—meningioma	0.00583	0.0367	CbGeAlD
Sucralfate—EGF—brain—meningioma	0.00537	0.0338	CbGeAlD
Sucralfate—FGF2—brain—meningioma	0.00474	0.0298	CbGeAlD
Sucralfate—ALB—brain—meningioma	0.00186	0.0117	CbGeAlD
Sucralfate—EGF—EGF/EGFR Signaling Pathway—PTEN—meningioma	0.00107	0.00127	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—PTEN—meningioma	0.00107	0.00127	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—PTEN—meningioma	0.00107	0.00127	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—PTEN—meningioma	0.00106	0.00126	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.00104	0.00124	CbGpPWpGaD
Sucralfate—EGF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00104	0.00124	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—PLAUR—meningioma	0.00104	0.00124	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.00104	0.00123	CbGpPWpGaD
Sucralfate—EGF—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	0.00102	0.00122	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—PDGFB—meningioma	0.00102	0.00121	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—PTEN—meningioma	0.00101	0.0012	CbGpPWpGaD
Sucralfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—AKT1—meningioma	0.001	0.00119	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—PTEN—meningioma	0.000997	0.00119	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.000997	0.00119	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—PTEN—meningioma	0.000997	0.00119	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—PTEN—meningioma	0.000989	0.00118	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—PTEN—meningioma	0.000988	0.00117	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—PTEN—meningioma	0.000981	0.00117	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—PTEN—meningioma	0.00098	0.00116	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—PDGFB—meningioma	0.000978	0.00116	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—PTEN—meningioma	0.000975	0.00116	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—meningioma	0.000958	0.00114	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—PTEN—meningioma	0.000942	0.00112	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000938	0.00112	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD34—meningioma	0.00093	0.00111	CbGpPWpGaD
Sucralfate—FGF2—Cardiac Hypertrophic Response—AKT1—meningioma	0.000926	0.0011	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CTSL—meningioma	0.000924	0.0011	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—PTEN—meningioma	0.000923	0.0011	CbGpPWpGaD
Sucralfate—EGF—PI-3K cascade—AKT1—meningioma	0.000922	0.0011	CbGpPWpGaD
Sucralfate—EGF—PI3K/AKT activation—AKT1—meningioma	0.0009	0.00107	CbGpPWpGaD
Sucralfate—EGF—GAB1 signalosome—AKT1—meningioma	0.000893	0.00106	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD34—meningioma	0.000891	0.00106	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—ERBB2—meningioma	0.000888	0.00106	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CTSL—meningioma	0.000887	0.00105	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.000883	0.00105	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TSHB—meningioma	0.000876	0.00104	CbGpPWpGaD
Sucralfate—EGF—ErbB1 downstream signaling—AKT1—meningioma	0.000873	0.00104	CbGpPWpGaD
Sucralfate—EGF—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	0.000873	0.00104	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TSHB—meningioma	0.000858	0.00102	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TSHB—meningioma	0.000858	0.00102	CbGpPWpGaD
Sucralfate—EGF—Immune System—CTSL—meningioma	0.00085	0.00101	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—ERBB2—meningioma	0.000849	0.00101	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—ERBB2—meningioma	0.000836	0.000994	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AP1B1—meningioma	0.000835	0.000992	CbGpPWpGaD
Sucralfate—FGF2—Integrins in angiogenesis—AKT1—meningioma	0.000831	0.000988	CbGpPWpGaD
Sucralfate—FGF2—Endochondral Ossification—AKT1—meningioma	0.000821	0.000976	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—PDGFB—meningioma	0.000802	0.000953	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—ERBB2—meningioma	0.000798	0.000949	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—ERBB2—meningioma	0.000797	0.000947	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—ERBB2—meningioma	0.000794	0.000944	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—ERBB2—meningioma	0.00079	0.00094	CbGpPWpGaD
Sucralfate—FGB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000787	0.000936	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—ERBB2—meningioma	0.000787	0.000935	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	0.000775	0.000922	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000771	0.000917	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000771	0.000917	CbGpPWpGaD
Sucralfate—FGF2—Disease—AP1B1—meningioma	0.000771	0.000916	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—PDGFB—meningioma	0.00076	0.000903	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—PTEN—meningioma	0.000757	0.0009	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—PDGFB—meningioma	0.000753	0.000895	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PDGFB—meningioma	0.000752	0.000894	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SMO—meningioma	0.000745	0.000885	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—ERBB2—meningioma	0.00074	0.00088	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—ERBB2—meningioma	0.00074	0.00088	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00074	0.00088	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—ERBB2—meningioma	0.000733	0.000872	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—PLAU—meningioma	0.000731	0.000868	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SMO—meningioma	0.00073	0.000867	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SMO—meningioma	0.00073	0.000867	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—ERBB2—meningioma	0.000727	0.000864	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—PTEN—meningioma	0.000724	0.000861	CbGpPWpGaD
Sucralfate—EGF—Disease—CST3—meningioma	0.000724	0.000861	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—meningioma	0.000724	0.000861	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—ERBB2—meningioma	0.000724	0.00086	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PGR—meningioma	0.000714	0.000849	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—PTEN—meningioma	0.000713	0.000847	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TP53—meningioma	0.00071	0.000843	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PGR—meningioma	0.0007	0.000832	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PGR—meningioma	0.0007	0.000832	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000696	0.000828	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—AKT1—meningioma	0.000689	0.000819	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—ERBB2—meningioma	0.000685	0.000814	CbGpPWpGaD
Sucralfate—FGA—Disease—HES1—meningioma	0.000683	0.000812	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—PTEN—meningioma	0.000681	0.000809	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—PTEN—meningioma	0.000679	0.000808	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PDGFB—meningioma	0.000678	0.000806	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—PTEN—meningioma	0.000677	0.000805	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—PTEN—meningioma	0.000674	0.000801	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—PTEN—meningioma	0.000671	0.000797	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.000661	0.000786	CbGpPWpGaD
Sucralfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00066	0.000785	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling of activated FGFR—AKT1—meningioma	0.00066	0.000784	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.000655	0.000779	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PDGFB—meningioma	0.000651	0.000774	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB4—AKT1—meningioma	0.000649	0.000772	CbGpPWpGaD
Sucralfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	0.000648	0.00077	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00064	0.000761	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.000631	0.00075	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—PTEN—meningioma	0.000631	0.00075	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—PTEN—meningioma	0.000631	0.00075	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—PTEN—meningioma	0.000625	0.000743	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—AKT1—meningioma	0.00062	0.000737	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—PTEN—meningioma	0.00062	0.000737	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—PTEN—meningioma	0.000617	0.000734	CbGpPWpGaD
Sucralfate—EGF—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.000617	0.000733	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—AKT1—meningioma	0.000617	0.000733	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—AKT1—meningioma	0.000614	0.00073	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—AKT1—meningioma	0.000611	0.000726	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000602	0.000716	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—AKT1—meningioma	0.000599	0.000712	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000594	0.000706	CbGpPWpGaD
Sucralfate—FGA—Disease—PDGFB—meningioma	0.000584	0.000694	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—PTEN—meningioma	0.000584	0.000694	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—AKT1—meningioma	0.000584	0.000694	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—AKT1—meningioma	0.000575	0.000683	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000575	0.000683	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—AKT1—meningioma	0.000575	0.000683	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—AKT1—meningioma	0.00057	0.000677	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—AKT1—meningioma	0.00057	0.000677	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—HES1—meningioma	0.000568	0.000675	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—AKT1—meningioma	0.000565	0.000672	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—AKT1—meningioma	0.000565	0.000671	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD34—meningioma	0.000564	0.00067	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—AKT1—meningioma	0.000562	0.000668	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.000559	0.000664	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	0.000552	0.000657	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—AKT1—meningioma	0.000543	0.000645	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000541	0.000643	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CTSL—meningioma	0.000538	0.000639	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TSHB—meningioma	0.000536	0.000637	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—AKT1—meningioma	0.000532	0.000632	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000509	0.000605	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—ERBB2—meningioma	0.000504	0.000599	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HES1—meningioma	0.000488	0.00058	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000481	0.000572	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—meningioma	0.00048	0.000571	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HES1—meningioma	0.000478	0.000569	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HES1—meningioma	0.000478	0.000569	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—meningioma	0.000471	0.000559	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—meningioma	0.000471	0.000559	CbGpPWpGaD
Sucralfate—FGF2—Disease—CST3—meningioma	0.000458	0.000545	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SMO—meningioma	0.000455	0.000541	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—ERBB2—meningioma	0.000454	0.00054	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PGR—meningioma	0.000437	0.000519	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ERBB2—meningioma	0.000436	0.000519	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—AKT1—meningioma	0.000436	0.000519	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PTEN—meningioma	0.00043	0.000511	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PDGFB—meningioma	0.000429	0.00051	CbGpPWpGaD
Sucralfate—EGF—Disease—HES1—meningioma	0.000426	0.000507	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PDGFB—meningioma	0.000418	0.000496	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—AKT1—meningioma	0.000417	0.000496	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PDGFB—meningioma	0.000412	0.00049	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—AKT1—meningioma	0.000411	0.000488	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PDGFB—meningioma	0.000409	0.000486	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PDGFB—meningioma	0.000409	0.000486	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—AKT1—meningioma	0.000406	0.000482	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000405	0.000482	CbGpPWpGaD
Sucralfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.000404	0.00048	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—AKT1—meningioma	0.000397	0.000472	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—AKT1—meningioma	0.000397	0.000472	CbGpPWpGaD
Sucralfate—EGF—Immune System—PDGFB—meningioma	0.000395	0.000469	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—AKT1—meningioma	0.000392	0.000466	CbGpPWpGaD
Sucralfate—FGA—Disease—ERBB2—meningioma	0.000391	0.000465	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—AKT1—meningioma	0.000391	0.000465	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—AKT1—meningioma	0.00039	0.000464	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—AKT1—meningioma	0.000388	0.000462	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PTEN—meningioma	0.000387	0.000461	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—AKT1—meningioma	0.000387	0.00046	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000381	0.000453	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PTEN—meningioma	0.000372	0.000442	CbGpPWpGaD
Sucralfate—EGF—Disease—PDGFB—meningioma	0.000365	0.000433	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000364	0.000432	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—AKT1—meningioma	0.000364	0.000432	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—AKT1—meningioma	0.000364	0.000432	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—AKT1—meningioma	0.00036	0.000428	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—AKT1—meningioma	0.000357	0.000425	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—AKT1—meningioma	0.000356	0.000423	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—meningioma	0.000346	0.000411	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000342	0.000407	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TSHB—meningioma	0.000339	0.000403	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.000337	0.000401	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—AKT1—meningioma	0.000337	0.0004	CbGpPWpGaD
Sucralfate—FGA—Disease—PTEN—meningioma	0.000334	0.000397	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—ERBB2—meningioma	0.000326	0.000387	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000322	0.000383	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HES1—meningioma	0.000298	0.000355	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—meningioma	0.000294	0.000349	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SMO—meningioma	0.000288	0.000343	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ERBB2—meningioma	0.000288	0.000342	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ERBB2—meningioma	0.00028	0.000333	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PGR—meningioma	0.000276	0.000328	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ERBB2—meningioma	0.000276	0.000328	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ERBB2—meningioma	0.000274	0.000326	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ERBB2—meningioma	0.000274	0.000326	CbGpPWpGaD
Sucralfate—FGF2—Disease—HES1—meningioma	0.00027	0.000321	CbGpPWpGaD
Sucralfate—EGF—Immune System—ERBB2—meningioma	0.000265	0.000315	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PDGFB—meningioma	0.000255	0.000303	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PDGFB—meningioma	0.00025	0.000297	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—AKT1—meningioma	0.000248	0.000295	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—AKT1—meningioma	0.000248	0.000295	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PTEN—meningioma	0.000245	0.000291	CbGpPWpGaD
Sucralfate—EGF—Disease—ERBB2—meningioma	0.000244	0.00029	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PLAUR—meningioma	0.00024	0.000286	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PTEN—meningioma	0.000239	0.000284	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PTEN—meningioma	0.000235	0.00028	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PTEN—meningioma	0.000234	0.000278	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PTEN—meningioma	0.000234	0.000278	CbGpPWpGaD
Sucralfate—FGF2—Disease—PDGFB—meningioma	0.000231	0.000274	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ALAD—meningioma	0.000229	0.000273	CbGpPWpGaD
Sucralfate—EGF—Immune System—PTEN—meningioma	0.000226	0.000268	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—AKT1—meningioma	0.000223	0.000265	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—meningioma	0.000214	0.000255	CbGpPWpGaD
Sucralfate—EGF—Disease—PTEN—meningioma	0.000208	0.000248	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—meningioma	0.000192	0.000229	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HES1—meningioma	0.000189	0.000225	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PDGFB—meningioma	0.000174	0.000207	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ERBB2—meningioma	0.000171	0.000203	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PLAU—meningioma	0.000169	0.0002	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ERBB2—meningioma	0.000167	0.000199	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—meningioma	0.000163	0.000194	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PDGFB—meningioma	0.000162	0.000192	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—meningioma	0.00016	0.00019	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—meningioma	0.00016	0.00019	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—meningioma	0.00016	0.00019	CbGpPWpGaD
Sucralfate—FGF2—Disease—ERBB2—meningioma	0.000155	0.000184	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TSHB—meningioma	0.000148	0.000176	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTEN—meningioma	0.000146	0.000173	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PTEN—meningioma	0.000143	0.00017	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—meningioma	0.000141	0.000168	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—meningioma	0.000138	0.000163	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—meningioma	0.000136	0.000161	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—meningioma	0.000135	0.00016	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—meningioma	0.000135	0.00016	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTEN—meningioma	0.000132	0.000157	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—meningioma	0.00013	0.000155	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—meningioma	0.00012	0.000143	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000111	0.000132	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ERBB2—meningioma	0.000108	0.000129	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—meningioma	9.96e-05	0.000118	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTEN—meningioma	9.23e-05	0.00011	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTEN—meningioma	9.04e-05	0.000107	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—meningioma	8.41e-05	0.0001	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—meningioma	8.23e-05	9.78e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—meningioma	7.6e-05	9.03e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—meningioma	6.78e-05	8.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—meningioma	6.3e-05	7.49e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—meningioma	5.72e-05	6.8e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—meningioma	5.32e-05	6.33e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTEN—meningioma	4.03e-05	4.79e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—meningioma	2.32e-05	2.76e-05	CbGpPWpGaD
